Literature DB >> 22498672

EXIT procedure for fetal neck masses.

Oluyinka O Olutoye1, Olutoyin A Olutoye.   

Abstract

PURPOSE OF REVIEW: The ex-utero intrapartum treatment (EXIT procedure) can be life-saving for fetuses with large neck masses. Advances in fetal imaging and access to prenatal care have improved the ability to anticipate and plan for the treatment of these fetuses. This review will highlight advances in imaging techniques, modification of anesthesia and case selection for the EXIT procedure. Long-term maternal and fetal outcomes will also be discussed. RECENT
FINDINGS: There have been relatively few articles published on this subject in the past 18 months. A better understanding of the effect of inhalational anesthetics on fetal cardiac function and some insight into the pharmacokinetics of narcotics while on uteroplacental support has been gained. Imaging characteristics that may improve patient selection have been proposed. The long-term outcomes of mothers undergoing fetal surgical procedures in general and specifically those undergoing EXIT procedures suggest that the EXIT procedure can be performed with minimal maternal morbidity in skilled hands. Furthermore, long-term neonatal outcomes appear to be improving, but further studies are needed.
SUMMARY: The EXIT procedure can be performed safely in a skilled multidisciplinary setting with minimal maternal and fetal morbidity and excellent fetal outcomes. Recent reports have helped further identify which fetuses will benefit from the EXIT procedure.

Entities:  

Mesh:

Year:  2012        PMID: 22498672     DOI: 10.1097/MOP.0b013e3283531b51

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  8 in total

1.  Fetal Oropharyngeal and Neck Tumors: Determination of the Need for Ex-Utero Intrapartum Treatment Procedure.

Authors:  Fatma Tuncay Özgünen; Ümran Küçükgöz Güleç; İsmail Cüneyt Evrüke; Süleyman Cansun Demir; Selim Büyükkurt; Hacer Yapıcıoğlu; Serdar İskit
Journal:  Balkan Med J       Date:  2015-04-01       Impact factor: 2.021

2.  Ex Utero Intrapartum Treatment (EXIT) for a Large Fetal Neck Mass.

Authors:  Manisha M Beck; Ekta Rai; Reeta Vijayaselvi; Mary John; Naina Picardo; Sridhar Santhanam; Maneesh Kumar; Benjamin J Ross
Journal:  J Obstet Gynaecol India       Date:  2017-06-05

Review 3.  Foetal surgery: Anaesthetic implications and strategic management.

Authors:  Bhavani Shankar Kodali; Shobana Bharadwaj
Journal:  Indian J Anaesth       Date:  2018-09

4.  Role of prenatal imaging in the diagnosis and management of fetal facio-cervical masses.

Authors:  Weizeng Zheng; Shuangshuang Gai; Jiale Qin; Fei Qiu; Baohua Li; Yu Zou
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

5.  Delivery of an Infant with Airway Compression Due to Cystic Hygroma at 37 Weeks' Gestation Requiring a Multidisciplinary Decision to Use a Combination of Ex Utero Intrapartum Treatment (EXIT) and Airway Palliation at Cesarean Section.

Authors:  Joel Sirianni; Joseph Abro; David Gutman
Journal:  Am J Case Rep       Date:  2021-01-03

6.  Super-resolution Reconstruction MRI Application in Fetal Neck Masses and Congenital High Airway Obstruction Syndrome.

Authors:  Nada Mufti; Michael Ebner; Premal Patel; Michael Aertsen; Trevor Gaunt; Paul D Humphries; Fonteini Emmananouella Bredaki; Richard Hewitt; Colin Butler; Magdalena Sokolska; Giles S Kendall; David Atkinson; Tom Vercauteren; Sebastien Ourselin; Pranav P Pandya; Jan Deprest; Andrew Melbourne; Anna L David
Journal:  OTO Open       Date:  2021-10-25

7.  Fetal giant right cervical cyst causing severe tracheal compression: A case report.

Authors:  Yanming Kang; Yushan Ma; Xiaoqin Jiang; Xuemei Lin; Fumin Zhao
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

8.  Ex-Utero Intrapartum Treatment (EXIT): indications and outcome in fetal cervical and oropharyngeal masses.

Authors:  Lutgardo García-Díaz; Angel Chimenea; Juan Carlos de Agustín; Antonio Pavón; Guillermo Antiñolo
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-07       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.